A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules

Abstract

ObjectiveTo establish a nomogram based on non-enhanced computed tomography(CT) imaging radiomics and clinical features for use in predicting the malignancy of sub-centimeter solid nodules (SCSNs).Materials and methodsRetrospective analysis was performed of records for 198 patients with SCSNs that were surgically resected and examined pathologically at two medical institutions between January 2020 and June 2021. Patients from Center 1 were included in the training cohort (n = 147), and patients from Center 2 were included in the external validation cohort (n = 52). Radiomic features were extracted from chest CT images. The least absolute shrinkage and selection operator (LASSO) regression model was used for radiomic feature extraction and computation of radiomic scores. Clinical features, subjective CT findings, and radiomic scores were used to build multiple predictive models. Model performance was examined by evaluating the area under the receiver operating characteristic curve (AUC). The best model was selected for efficacy evaluation in a validation cohort, and column line plots were created.ResultsPulmonary malignant nodules were significantly associated with vascular alterations in both the training (p < 0.001) and external validation (p < 0.001) cohorts. Eleven radiomic features were selected after a dimensionality reduction to calculate the radiomic scores. Based on these findings, three prediction models were constructed: subjective model (Model 1), radiomic score model (Model 2), and comprehensive model (Model 3), with AUCs of 0.672, 0.888, and 0.930, respectively. The optimal model with an AUC of 0.905 was applied to the validation cohort, and decision curve analysis indicated that the comprehensive model column line plot was clinically useful.ConclusionPredictive models constructed based on CT-based radiomics with clinical features can help clinicians diagnose pulmonary nodules and guide clinical decision making.

Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma

“…One study identified a radiomic signature discerned from conventional CT that reached an AUC of 0.92 for overall survival in a validation set of patients with melanoma treated with pembrolizumab [13]. Similar studies have demonstrated the effectiveness of CT-based radiomic signatures in predicting overall survival in patients with NSCLC treated with nivolumab [29]. Such signatures can be developed for other imaging modalities, such as FDG-PET scans.…”

A nomogram combining CT-based radiomic features with clinical features for the differentiation of benign and malignant cystic pulmonary nodules

“…Several prediction models, such as the Mayo model [ 10 ], the VA model [ 11 ], the Brock model [ 12 ], and the PKUPH model [ 13 ], have been designed for evaluating benign and malignant pulmonary nodules. Partial prediction models have incorporated advanced quantitative imaging methods, including CT attenuation, tumor diameter growth rate, and imaging omics [ 15 , 22 , 23 ]. However, all these classical models have certain limitations.…”

An Integrated Clinical and Computerized Tomography-Based Radiomic Feature Model to Separate Benign from Malignant Pleural Effusion

“…Within thoracic radiology, radiomic techniques have been extensively explored for their potential to distinguish benign and malignant lesions, predict tumor classification, and assess treatment outcome [8‒11]. The combination of radiomic features with clinical factors has shown promise in improving the accuracy of disease diagnosis [12]. However, there is a notable gap in the existing research regarding integrating radiomic features and clinical factors to construct a radiomic-clinical combined model specifically for distinguishing the nature of PE.…”